Pressure Is Lazy. Pain Is Effective.

Read time: 5 minutes

Welcome to the Succession newsletter where 1,000+ life science sales reps improve their skills in 5 minutes per week. If you’re getting value from these newsletters, we'd love it if you could forward it along to your sales colleagues. If you’re new here, subscribe below.

Pain Beats Pressure: The Real Trigger for Scientists

It’s a seductive thought: if only you apply enough urgency, your prospect will sign the deal. Send a few “just checking in” emails, slash the price before quarter-end, add a countdown clock.

But in life science sales, pressure doesn’t drive action; remember Newton's 3rd law, it breeds resistance. Scientists are wired to question and look for risk. They see through gimmicks. They’ve been trained to avoid bias, not to rush into decisions.

What actually moves them? Pain. Real, operational, measurable pain. The kind of pain that’s costing them time, money, headcount, or credibility. In fact, deals stall not because your science isn’t good enough, but because that pain has never been made explicit.

Why Pressure Fails With Scientific Buyers

Here’s a hard truth: discounting trains your prospects to wait. If you always resort to end-of-quarter price drops, you teach buyers to hold out. Likewise, repeated “just checking in” emails make you easy to ignore; your prospect learns that nothing changes if they don’t respond.

A previous newsletter on stalled deals explains that real urgency comes from tying your solution to a high-priority problem or critical event. Scientists will move mountains to meet a project milestone or save a program from delay. They will not move for a random 5% off.

Moreover, scientists carry a heavy dose of status quo bias. If their current workflow “sort of works,” they see no reason to risk the unknown. Your job is not to push harder, it’s to reveal the cost of inaction: missed grant deadlines, wasted reagents, data that never sees publication.

The Discipline of Discovery: Slow Down to Speed Up

Most sales reps lose deals in the first five minutes, not because they pitch wrong, but because they accept vague answers and move on. “Throughput is a bottleneck.” “Reproducibility has been a challenge.” Those statements sound helpful. They aren’t. They’re summaries, not problems. Without specifics, you can’t anchor value to anything.

Instead of nodding and pushing ahead, do what we call “staying with the detail.” Two simple prompts work wonders:

• “Walk me through what that actually looks like.”

• “Can you give me a specific example?”

These questions force your prospect out of summary mode and into story mode. Now “reproducibility challenges” turn into failed runs, lost samples, two extra weeks per cycle, and £10k in wasted reagents. That is pain you can work with.

Discovery isn’t an interrogation; it’s a conversation. You’re moving from symptoms → root cause → business impact before ever talking about your solution. Only then does urgency emerge, naturally and authentically.

When Pain Is Still Abstract, Pressure Sneaks In

This is usually the moment where sellers lose their nerve!

A prospect describes a technical issue, and the rep immediately tries to make it meaningful by jumping to outcomes, ROI, or impact statements. Not because they are wrong, but because the pain still feels a bit thin.

That instinct is the tell.

If you feel the urge to “frame the value”, it is often because the problem has not been made painful enough yet.

A 30% reduction in assay turnaround does not create urgency on its own. Neither does “better reproducibility” nor “higher throughput”. Those are improvements. Improvements are nice. They do not force decisions. Pain does.

Pain lives in the experience of the problem. The failed run at 6 pm. The experiment has to be repeated again. The project is slipping another week while everyone politely pretends it is fine.

Until the conversation stays there long enough for that reality to surface, any attempt to move things forward starts to feel like pressure.

So instead of translating the problem upwards, stay with it longer, sit with the pain!

What actually happens when turnaround slips?
Who notices first?
What breaks downstream?
What is the knock-on effect the second or third time it happens?

You do not need to exaggerate. You do not need to persuade. You just need to stop rescuing the conversation too early.
Once the pain is concrete, you will not need to push. Momentum shows up on its own because the buyer can finally feel the cost of staying exactly where they are.

When Pain Becomes Explicit, Pressure Becomes Redundant

Once the real cost of the problem surfaces, you do not need to manufacture urgency. The buyer does that for you.

When a prospect realises that each failed run is quietly pushing their next clinical milestone back by two weeks, or that their current CRO has managed to burn through half the budget with nothing useful to show for it, something shifts.

They stop being interested.
They start being motivated.

That is usually the moment the questions change. Not “can you send something over?” but “how quickly could this actually work for us?”

This is a pattern that shows up again and again. When the pain is clear and specific, urgency is no longer something you apply. It emerges naturally because the cost of doing nothing has finally become uncomfortable enough to deal with.

No pressure required.

Why This Still Goes Wrong

Most sellers actually understand all of this.
They know pressure does not work. They know discovery matters. They know vague problems do not close.

And yet, under pressure, they abandon it.

A deal goes quiet. A quarter is ending. Someone asks for an update. And suddenly the discipline disappears. Follow-ups get heavier. Timelines get invented. Discounts appear.

Not because the approach was wrong, but because it takes nerve to stay patient when the outcome is uncertain.

Scientific sales reward that nerve.

The people who win are not the ones who push hardest. They are the ones who stay with the problem longest, even when it would be easier to move on.

That is not a theory. It is pattern recognition.

Will you try it, will you sit with the pain?

Further Reading & Listening

If you want to learn more, ask AI Nick for help.
https://www.delphi.ai/successionbio

Try these questions:
-How do I create urgency without discounts?
-What discovery questions surface real pain?
-How do I avoid pain-and-pitch?
-How do I link pain to business impact?
-What podcast covers staying with pain?

1. Lead Generation: We’ll build target lists, write scientifically relevant messaging, and send messages on your behalf to book qualified sales meetings with biotech and pharma companies.

2. Training for Reps: A skill development platform for life science sales reps who want to improve their sales skills, exceed their quota, and take the next step in their career.

3. Training for Teams: If you want to upskill your team around prospecting, driving to close, key account management, AI, or any other topic, we can put together a training plan specific to your organization’s needs.

4. Strategy Call: Need more than training? Want help implementing and executing your sales strategy? In a 30-minute call, we will assess your company’s current situation and identify growth opportunities.